Search results
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive ...
- Products & Services
Bachem was founded on the synthesis of amino acid...
- About Bachem
Bachem is a leading, innovation-driven company specializing...
- News & Events
As Bachem is the world’s leading company in developing and...
- Knowledge Center
Bachem provides a wide range of documentation and practical...
- Careers
Bachem is committed to working with and providing reasonable...
- Contact
Bachem AG Hauptstrasse 144 4416 Bubendorf Switzerland. Tel...
- CMC Development
Certainly, Bachem's expertise in peptides, their...
- Commercial API
You come first – We pride ourselves on a consistently high...
- Products & Services
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a ...
Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals. It specializes in the commercial production of peptides and complex organic compounds as active pharmaceutical ingredients, in the production of peptide-based biochemicals and in the development of manufacturing processes for ...
Get the latest BACHEM HOLDING AG (BANB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
8 BACHEM ANNUAL REPORT 2023 VISION, MISSION AND STRATEGIC FOUNDATIONS Bachem offers a differentiated value proposition that addresses pharma and biotech companies’ unique needs in developing and manufacturing peptides and oligonucleotides. In the world of active pharmaceutical ingredients, peptides and oligonucleotides, also known as TIDES,
Mar 7, 2024 · Bachem began construction of the world’s most advanced production plant for large volumes of peptides and oligonucleotides in 2021 (building “K”) in Bubendorf. Production in building “K” is to commence in the second half of 2024 and capacity will then be expanded on a modular basis.
People also ask
Who is Bachem Holding AG?
What does Bachem do?
What makes Bachem a successful company?
Where is Bachem headquartered?
Jun 24, 2024 · Bachem Holding AG (BANB:SWX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
